Drug Recalls

Here you'll find every drug recall the FDA has issued, including prescription medications, over-the-counter drugs, compounded pharmacy products, and dietary supplements. We've been tracking these since 2006 and our database updates several times a day so you're always looking at current information.

Drugs get recalled for a number of reasons: contamination during manufacturing, incorrect potency or dosage, failed quality testing (like dissolution or stability tests), sterility problems in injectable products, or labeling and packaging errors that could cause someone to take the wrong dose. If you find a product on this list that you use, please follow the instructions provided by the FDA to take the necessary precautions.

17,529 total recalls
1 this month

Showing 5601–5620 of 17,529 recalls

June 3, 2020· WALKER EMULSIONS INC

Recalled Item: Walker Hand Sanitizer

The Issue: Undeclared Excipients

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
June 3, 2020· A.P. Deauville, LLC

Recalled Item: Soft Whisper by Powerstick Dandruff Shampoo (Pyrithione Zinc)

The Issue: cGMP Deviations: Soft Whisper Dandruff Shampoo was produced

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
June 2, 2020· Teva Pharmaceuticals USA

Recalled Item: Metformin Hydrochloride Extended - Release Tablets

The Issue: CGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA) impurity

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
June 2, 2020· Teva Pharmaceuticals USA

Recalled Item: Metformin Hydrochloride Extended-Release Tablets

The Issue: CGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA) impurity

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
June 1, 2020· WORLD EVENT PROMOTIONS, LLC

Recalled Item: Handese Advanced Instant Hand Sanitizer (Ethyl Alcohol 70%)

The Issue: Subpotent Drug: Product was found to be subpotent

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
May 29, 2020· Amneal Pharmaceuticals of New York, LLC

Recalled Item: amneal Metformin Hydrochloride Extended-Release Tablets

The Issue: CGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA) impurity

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
May 29, 2020· Amneal Pharmaceuticals of New York, LLC

Recalled Item: amneal Metformin Hydrochloride Extended-Release Tablets

The Issue: CGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA) impurity

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
May 29, 2020· Amneal Pharmaceuticals of New York, LLC

Recalled Item: amneal Metformin Hydrochloride Extended-Release Tablets

The Issue: CGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA) impurity

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
May 29, 2020· Amneal Pharmaceuticals of New York, LLC

Recalled Item: amneal Metformin Hydrochloride Extended-Release Tablets

The Issue: CGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA) impurity

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
May 29, 2020· Amneal Pharmaceuticals of New York, LLC

Recalled Item: amneal Metformin Hydrochloride Extended-Release Tablets

The Issue: CGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA) impurity

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
May 29, 2020· Amneal Pharmaceuticals of New York, LLC

Recalled Item: amneal Metformin Hydrochloride Extended-Release Tablets

The Issue: CGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA) impurity

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
May 29, 2020· Amneal Pharmaceuticals of New York, LLC

Recalled Item: amneal Metformin Hydrochloride Extended-Release Tablets

The Issue: CGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA) impurity

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
May 29, 2020· Amneal Pharmaceuticals of New York, LLC

Recalled Item: amneal Metformin Hydrochloride Extended-release Tablets

The Issue: CGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA) impurity

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
May 29, 2020· Amneal Pharmaceuticals of New York, LLC

Recalled Item: amneal Metformin Hydrochloride Extended-Release Tablets

The Issue: CGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA) impurity

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
May 29, 2020· Amneal Pharmaceuticals of New York, LLC

Recalled Item: amneal Metformin Hydrochloride Extended-release Tablets

The Issue: CGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA) impurity

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
May 29, 2020· Amneal Pharmaceuticals of New York, LLC

Recalled Item: amneal Metformin Hydrochloride Extended-Release Tablets

The Issue: CGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA) impurity

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
May 29, 2020· Amneal Pharmaceuticals of New York, LLC

Recalled Item: amneal Metformin Hydrochloride Extended-release Tablets

The Issue: CGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA) impurity

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
May 29, 2020· Pfizer Inc.

Recalled Item: Unasyn (ampicillin sodium/sulbacatam) for injection

The Issue: Presence of Particulate Matter: particulate matter identified after

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
May 28, 2020· Glaxosmithkline Consumer Healthcare Holdings

Recalled Item: Gaviscon Regular Strength Liquid Antacid Cool Mint

The Issue: Labeling: Label lacks warning - Magnesium safety warning

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
May 28, 2020· Glaxosmithkline Consumer Healthcare Holdings

Recalled Item: Gaviscon Extra Strength Liquid Antacid Extra Strength Cherry

The Issue: Labeling: Label lacks warning - Magnesium safety warning

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund